Series A for Coherex brings in $8.5mm
Executive Summary
Coherex Medical (developing technologies to treat heart defects) raised $8.5mm in a private placement of Series A convertible preferred shares led by Oxford Bioscience and vSpring Capital.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice